Skip to main content
ANNX
NASDAQ Life Sciences

Phase 3 ARCHER II Enrollment Complete; Topline Data Due Q4 2026

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$5.86
Mkt Cap
$950.287M
52W Low
$2.03
52W High
$7.18
52W Position info
189% above low
Off High info
18% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ANNX has more than doubled off its 52-week low of $2.03.

Summary

Annexon completed enrollment of 659 patients in the pivotal Phase 3 ARCHER II trial for vonaprument, a C1q inhibitor, with topline results expected in Q4 2026. This follows the recent ASRS presentation of Phase 2 baseline characteristics and keeps the program on track for a potential regulatory filing. The company also granted 335,000 inducement options to two new hires at a $6.50 strike, a modest equity award. With a market cap near $950M and cash runway into H2 2027, the ARCHER II readout is the next major binary event for the stock.

At the time of this announcement, ANNX was trading at $5.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $950.3M. The 52-week trading range was $2.03 to $7.18. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

ANNX - Latest Insights

ANNX
Nov 09, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.23
Real-time Price: $3.88 info
Change: -$0.350 (-8%) info
Market Cap: $747.795M info
ANNX
Nov 09, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.23
Real-time Price: $3.88 info
Change: -$0.350 (-8%) info
Market Cap: $747.795M info
ANNX
Aug 12, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $3.88 info
Change: -$1.47 (-27%) info
Market Cap: $747.795M info
ANNX
Aug 12, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.01
Real-time Price: $3.88 info
Change: -$1.13 (-23%) info
Market Cap: $747.795M info
ANNX
Aug 12, 2026, 6:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.46
Real-time Price: $3.88 info
Change: -$1.58 (-29%) info
Market Cap: $747.795M info